Carolyn D. Runowicz, Herbert Wertheim College of Medicine, Florida International University; Karen S. Henry, Sylvester Cancer Center at the University of Miami, Miami, FL; Corinne R. Leach, Rebecca L. Cowens-Alvarado, Rachel S. Cannady, and Samuel J. LaMonte, American Cancer Society, Atlanta, GA; N. Lynn Henry, University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI; Heather T. Mackey, Oncology Nursing Society, Pittsburgh; Linda A. Jacobs, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Mandi L. Pratt-Chapman, The George Washington University Cancer Institute, Washington, DC; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; Arti Hurria, City of Hope, Duarte; Patricia A. Ganz, Schools of Medicine and Public Health, University of California, Los Angeles, CA; Lawrence B. Marks, University of North Carolina, Chapel Hill, NC; Ellen Warner, University of Toronto, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; and Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA doi: 10.3322/caac.21319. Available online at cacancerjournal.com.
J Clin Oncol. 2016 Feb 20;34(6):611-35. doi: 10.1200/JCO.2015.64.3809. Epub 2015 Dec 7.
The purpose of the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline is to provide recommendations to assist primary care and other clinicians in the care of female adult survivors of breast cancer. A systematic review of the literature was conducted using PubMed through April 2015. A multidisciplinary expert workgroup with expertise in primary care, gynecology, surgical oncology, medical oncology, radiation oncology, and nursing was formed and tasked with drafting the Breast Cancer Survivorship Care Guideline. A total of 1,073 articles met inclusion criteria; and, after full text review, 237 were included as the evidence base. Patients should undergo regular surveillance for breast cancer recurrence, including evaluation with a cancer-related history and physical examination, and should be screened for new primary breast cancer. Data do not support performing routine laboratory tests or imaging tests in asymptomatic patients to evaluate for breast cancer recurrence. Primary care clinicians should counsel patients about the importance of maintaining a healthy lifestyle, monitor for post-treatment symptoms that can adversely affect quality of life, and monitor for adherence to endocrine therapy. Recommendations provided in this guideline are based on current evidence in the literature and expert consensus opinion. Most of the evidence is not sufficient to warrant a strong evidence-based recommendation. Recommendations on surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of physical and psychosocial long-term and late effects of breast cancer and its treatment, health promotion, and care coordination/practice implications are made.This guideline was developed through a collaboration between the American Cancer Society and the American Society of Clinical Oncology and has been published jointly by invitation and consent in both CA: A Cancer Journal for Clinicians and Journal of Clinical Oncology. All rights reserved. No part of this document may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission by the American Cancer Society or the American Society of Clinical Oncology.
美国癌症协会/美国临床肿瘤学会乳腺癌生存护理指南的目的是提供建议,以协助初级保健和其他临床医生为乳腺癌女性成年幸存者提供护理。通过 PubMed 对文献进行了系统回顾,检索时间截至 2015 年 4 月。成立了一个具有初级保健、妇科、外科肿瘤学、医学肿瘤学、放射肿瘤学和护理专业知识的多学科专家工作组,负责起草乳腺癌生存护理指南。共有 1073 篇文章符合纳入标准;经过全文审查,共有 237 篇文章被纳入证据基础。患者应定期进行乳腺癌复发监测,包括进行癌症相关病史和体格检查,并应筛查新的原发性乳腺癌。数据不支持对无症状患者进行常规实验室检查或影像学检查以评估乳腺癌复发。初级保健临床医生应向患者提供保持健康生活方式的重要性的咨询,监测可能影响生活质量的治疗后症状,并监测内分泌治疗的依从性。本指南中的建议是基于文献中的现有证据和专家共识意见。大多数证据不足以保证有强有力的基于证据的建议。对乳腺癌复发监测、第二原发性癌症筛查、乳腺癌及其治疗的身体和心理社会长期和晚期影响的评估和管理、健康促进以及护理协调/实践影响的建议。本指南是由美国癌症协会和美国临床肿瘤学会合作制定的,并经 CA: A Cancer Journal for Clinicians 和 Journal of Clinical Oncology 两家杂志共同邀请和同意出版。版权所有。未经美国癌症协会或美国临床肿瘤学会书面许可,本文件的任何部分不得以任何形式或手段复制或传播,包括影印、录制或任何信息存储和检索系统。